Business Standard

Lupin in fast lane with 5 launches in 15 days

New products expected to offset price erosion in the US

Lupin in fast lane with 5 launches in 15 days
Premium

Aneesh PhadnisAbhineet Kumar Mumbai
Mumbai-based Lupin launched the generic version of Allergan’s contraceptive pill, Minastrin, in the US, with an 180-day sales exclusivity. The product has a market size of $361 million and will provide the Indian company significant profit opportunity. 

This is the fifth product launch by the company in the last 15 days and the ninth one since its Goa plant got a final approval from the US Food and Drug Administration (USFDA) in November. These product launches come at a time when Indian generic makers are facing pricing pressure in US markets.

“The company is significantly dependent on two products (Glumetza and Fortamet),

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in